Century Therapeutics
Philadelphia-based Century Therapeutics innovates in stem cell therapy and research for global cancer treatment.
Founded
2018Philadelphia-based Century Therapeutics innovates in stem cell therapy and research for global cancer treatment.
Founded in Philadelphia, Pennsylvania, Century Therapeutics is a biotech company dedicated to revolutionizing cancer treatment through the development of allogeneic, induced pluripotent stem cell (iPSC)-derived NK and T cell therapies. Their core mission is to overcome the limitations of first-generation cell therapies and provide curative solutions for cancer, as well as autoimmune and inflammatory diseases. By leveraging precision design and innovative stem cell technology, Century Therapeutics aims to deliver transformative and enduring impacts on patient care.
Notable figures affiliated with Century Therapeutics include industry-leading scientists and executives with extensive experience in biotechnology and oncology. The company has attracted significant investment from prominent venture capital firms and strategic partners. Key achievements include presenting promising interim results from their Phase ELiPSE study at the ASCO Annual Meeting, showcasing a manageable safety profile for their lead candidate, CNTY-. Century Therapeutics' pioneering approach has the potential to significantly advance the field of cell therapy and improve outcomes for patients worldwide.
Companies similar to Century Therapeutics include Celularity, Cello Therapeutics, Ernexa Therapeutics and Allogene Therapeutics.
Century Therapeutics was founded in 2018.
Century Therapeutics' headquarters is located in Philadelphia, PA, US.
Century Therapeutics' most recent funding round was for $150M (USD) in January 2022.
As of Jan 10, 2022, Century Therapeutics has raised a total of $560M (USD).
Century Therapeutics has 184 employees as of Feb 6, 2024.
Ernexa Therapeutics
eternatx.com
